Prior studies implicated MEIS1 and MEIS2 as putative tumor suppressors in PrCa based upon clinical associations between retention of tumor expression and overall survival or risk of metastasis (Bhanvadia et al., 2018; Chen et al., 2012). This evidence concerns the gene MEIS2 and neoplasm.